Orphenadrine Citrate
Medicare prescription drug cost, prescriptions and prescribers, 2024
$236K
Medicare cost, 2024
$236K
Medicare cost, 2024
Medicare drug plans spent $235,935 on Orphenadrine Citrate in 2024, for 4,520 prescriptions and refills filled by 3,215 patients. Spending fell 56% from 2023 to 2024. Puerto Rico accounts for the most spending ($205,516, 87% of the total).
Medicare cost, 2024
$236K
-55.6% from 2023
Prescriptions
4,520
$52.20 per claim
Patients
3,215
1,288 prescribers
Total spending, 2024
$236K
$73.39 per patient
Questions and answers
How much does Medicare spend on Orphenadrine Citrate?
Medicare prescription drug plans paid $236K for Orphenadrine Citrate in 2024, for 4,520 prescriptions and refills to 3,215 patients (down 55.6% from 2023). The average cost per claim was $52.20.
Which state spends the most on Orphenadrine Citrate?
Puerto Rico had the highest Medicare cost for Orphenadrine Citrate in 2024: $206K for 4,267 claims, followed by Illinois ($8,806).
Who prescribes Orphenadrine Citrate the most?
Jan J Kraemer, interventional pain management in San Juan, PR, had the highest Medicare cost for Orphenadrine Citrate in 2024: 23 claims costing $8,728.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Orphenadrine Citrate was $236K in 2024, after a high of $747K in 2022.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Orphenadrine Citrate, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jan J Kraemer San Juan, PR | Interventional Pain Management | 23 | 12 | $8,728 |
| Rafael Soto Toa Baja, PR | General Practice | 23 | Under 11 | $7,087 |
| Richard Graulau Rosario Cidra, PR | General Practice | 58 | 21 | $7,012 |
| Kurt R Bravata Buffalo, MO | Family Practice | 22 | Under 11 | $5,029 |
| Roberto Ruiz-Lopez San Juan, PR | Internal Medicine | 17 | Under 11 | $3,859 |
| George J Urban Chicago, IL | Internal Medicine | 24 | Under 11 | $3,339 |
| Alfred R Johnson Richardson, TX | Internal Medicine | 17 | Under 11 | $3,221 |
| Angel Vazquez Urquia Corozal, PR | General Practice | 27 | Under 11 | $2,976 |
| Maricarmen Quinones San Juan, PR | General Practice | 15 | Under 11 | $2,958 |
| Maria C Cruz-Lartigaut Vega Alta, PR | Neurology | 22 | Under 11 | $2,774 |
| Edgar J Ramos Mendez Barceloneta, PR | Family Practice | 40 | 26 | $2,463 |
| Hector A Tirado Davila Sr. Bayamon, PR | General Practice | 49 | 25 | $2,459 |
| Carlos A Gil Barceloneta, PR | General Practice | 29 | 18 | $2,204 |
| Merle L Diamond Chicago, IL | Internal Medicine | 15 | Under 11 | $1,669 |
| Javier F Rios III Carolina, PR | Physical Medicine and Rehabilitation | 13 | Under 11 | $1,620 |
| Luis A Paz Reyes Vega Baja, PR | General Practice | 20 | Under 11 | $1,616 |
| Aurea T Negron Valcarcel Hato Rey, PR | Anesthesiology | 14 | Under 11 | $1,579 |
| Luis F Garcia-Jaunarena San Juan, PR | Rheumatology | 16 | Under 11 | $1,287 |
| Ana G Beauchamp-Irizarry Ponce, PR | Internal Medicine | 16 | 11 | $1,286 |
| Kate E Hesser Crete, NE | Family Practice | 25 | Under 11 | $1,213 |
| Frank Campos Lopez Ciales, PR | General Practice | 15 | Under 11 | $1,147 |
| Jorge L Torres-Martinez Salinas, PR | General Practice | 34 | 26 | $1,126 |
| Jose M Mendez Jiminian Fajardo, PR | General Practice | 19 | Under 11 | $1,111 |
| Daylin Guerrero Caballero Lares, PR | General Practice | 14 | Under 11 | $1,015 |
| Ana P Castro Corozal, PR | Internal Medicine | 14 | Under 11 | $974 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,688 | 7,552 | 4,889 | $748K |
| 2023 | 1,691 | 7,770 | 5,305 | $532K |
| 2024 | 1,288 | 4,520 | 3,215 | $236K |
Makers, 2024
Spending by manufacturer as listed in the spending data
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 53
- RxNorm concept IDs
- 994521, 994541
- Application numbers
- ANDA040284, ANDA040327, ANDA040463, ANDA084779, ANDA090585
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 755 side-effect reports named orphenadrine citrate (reports from 2004 on). 518 of them (68.6%) were serious, 73 named a death and 215 named a hospital stay. The reactions named most often were pain, nausea and fatigue. 168 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
755
25 in 2025 (+0.0% from 2024)
Serious
68.6%
518 reports
Deaths named
73
9.7% of reports
Hospital stays
215
28.5% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Orphenadrine Citrate?
755 reports from 2004 through September 2026 named orphenadrine citrate. 518 of them (68.6%) were serious, 73 named a death and 215 named a hospital stay.
What are the most reported side effects of Orphenadrine Citrate?
72 reports named pain, the reaction named most often, followed by nausea (71) and fatigue (59). In the last 5 years the reaction named most often was pain (20 reports). A report can name several reactions.
How many side-effect reports named Orphenadrine Citrate in 2025?
25 reports were received in 2025 (+0.0% from 2024). 2026 so far: 26 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Orphenadrine Citrate caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Orphenadrine Citrate caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with orphenadrine citrate: Orphenadrine Citrate Er
- Drug approvals (5 approvals on file for orphenadrine citrate) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (orphenadrine citrate) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.